Dhodh Mouse Pre-designed siRNA Set A contains three designed siRNAs for Dhodh gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

Dhodh Rat Pre-designed siRNA Set A contains three designed siRNAs for Dhodh gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

DHODH-IN-25 (Compound 25) is an orally active dihydroorotate dehydrogenase (DHODH) inhibitor with an IC50 value of 5.4 nM for human DHODH. DHODH-IN-25 can be used for the study of acute myeloid leukemia (AML)[1].

DHODH-IN-26 (compound B2) is a mitochondria-targeting DHODH inhibitor. DHODH-IN-26 shows anticancer activity, triggers the formation of reactive oxygen species (ROS), promots mitochondrial lipid peroxidation, and induces ferroptosis[1].

DHPS Human Pre-designed siRNA Set A contains three designed siRNAs for DHPS gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

DHRS1 Human Pre-designed siRNA Set A contains three designed siRNAs for DHRS1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

DHRS11 Human Pre-designed siRNA Set A contains three designed siRNAs for DHRS11 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

DHRS2 Human Pre-designed siRNA Set A contains three designed siRNAs for DHRS2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

DHRS3 Human Pre-designed siRNA Set A contains three designed siRNAs for DHRS3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

DHRS4 Human Pre-designed siRNA Set A contains three designed siRNAs for DHRS4 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

DHRS7 Human Pre-designed siRNA Set A contains three designed siRNAs for DHRS7 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

DHRS7B Human Pre-designed siRNA Set A contains three designed siRNAs for DHRS7B gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

DHRS9 Human Pre-designed siRNA Set A contains three designed siRNAs for DHRS9 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

DHRSX Human Pre-designed siRNA Set A contains three designed siRNAs for DHRSX gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

DHTKD1 Human Pre-designed siRNA Set A contains three designed siRNAs for DHTKD1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

DHX-SP is a fluorescent probe, which visualizes superoxide anion (O2·–) and peroxynitrite (ONOO–) during ferroptosis of PC12 cells and in the Parkinson’s disease model[1].

DHX15 Human Pre-designed siRNA Set A contains three designed siRNAs for DHX15 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

DHX16 Human Pre-designed siRNA Set A contains three designed siRNAs for DHX16 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

DHX29 Human Pre-designed siRNA Set A contains three designed siRNAs for DHX29 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

DHX30 Human Pre-designed siRNA Set A contains three designed siRNAs for DHX30 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

DHX33 Human Pre-designed siRNA Set A contains three designed siRNAs for DHX33 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

DHX34 Human Pre-designed siRNA Set A contains three designed siRNAs for DHX34 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

DHX35 Human Pre-designed siRNA Set A contains three designed siRNAs for DHX35 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

DHX36 Human Pre-designed siRNA Set A contains three designed siRNAs for DHX36 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

DHX37 Human Pre-designed siRNA Set A contains three designed siRNAs for DHX37 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

DHX38 Human Pre-designed siRNA Set A contains three designed siRNAs for DHX38 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

DHX40 Human Pre-designed siRNA Set A contains three designed siRNAs for DHX40 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

DHX58 Human Pre-designed siRNA Set A contains three designed siRNAs for DHX58 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

DHX8 Human Pre-designed siRNA Set A contains three designed siRNAs for DHX8 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

DHX9 Human Pre-designed siRNA Set A contains three designed siRNAs for DHX9 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

DIABLO Human Pre-designed siRNA Set A contains three designed siRNAs for DIABLO gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Diacetonamine is a sporulation inducing factor which can be extracted from soybean curd residue[1].

Diacetoxyscirpenol-13C19 is 13C labeled 2-Acetylfuran (HY-W015912). 2-Acetylfuran (2-Furyl methyl ketone), an important flavour compound or intermediate in foods, is isolated from essential oils, sweet corn products, fruits and flowers. 2-Acetylfuran also can be formed from glucose and glycine by Maillard reaction. 2-Acetylfuran can be used to synthesis Cefuroxime[1][2].

Diamsar hydrochloride is a bifunctional chelator[1].

DIAPH1 Human Pre-designed siRNA Set A contains three designed siRNAs for DIAPH1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

DIAPH2 Human Pre-designed siRNA Set A contains three designed siRNAs for DIAPH2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

DIAPH3 Human Pre-designed siRNA Set A contains three designed siRNAs for DIAPH3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Diatrizoic acid (Standard) is the analytical standard of Diatrizoic acid. This product is intended for research and analytical applications. Diatrizoic acid (Diatrizoate) is an iodinated radiocontrast agent and has the potential for radiographic imaging of the airways. Diatrizoic acid induces mitochondrial turnover and oxidative stress, and activating apoptosis by dysregulating calcium[1][2].

Diaza-15-crown-5 extends the lifetime of M intermediates in BR membranes. Diaza-15-crown-5 is a crown ether compound that alters the surface charge of BR membranes. Diaza-15-crown-5 changes the surface charge of the BR film. and overall membrane stability. Diaza-15-crown-5 allows the M state to be maintained for a longer period of time[1].

Diaza-15-crown-5 extends the lifetime of M intermediates in BR membranes. Diaza-15-crown-5 is a crown ether compound that alters the surface charge of BR membranes. Diaza-15-crown-5 changes the surface charge of the BR film. and overall membrane stability. Diaza-15-crown-5 allows the M state to be maintained for a longer period of time[1].

Dibenzo-24-crown-8-ether is a phase transfer catalyst that can reduce H2PtCl6·6H2O and FeCl2·4H2O in a thermal system to synthesize 17 nm monodispersed iron-platinum (FePt) alloy nanoparticles[1].

Dibenzyl-14-crown-4 (6,6-Dibenzyl-1,4,8,11-tetraoxacyclotetradecane) is a crown ether derivate, which serves as neutral carrier in PVC ion-selective electrode, improves the Li+ selectivity against Na+ and K+[1].

DICER1 Human Pre-designed siRNA Set A contains three designed siRNAs for DICER1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Dichlorogelignate (compound 4) is a selective inhibitor of topoisomerase II (Topo II). Dichlorogelignate has 100% inhibition at 50 μM[1].

Dichlorphenamide (Standard) is the analytical standard of Dichlorphenamide. This product is intended for research and analytical applications. Dichlorphenamide (Diclofenamide) is an orally active, specific, carbonic anhydrase inhibitor. Dichlorphenamide can reduce intraocular pressure by inhibiting the secretion of water from the eye. Dichlorphenamide can be used for glaucoma research[1].

Diclofenac methyl ester is a diclofenac (HY-15036) derivative, which exhibits acute cytotoxicity with a LC50 of 0.5 mg/L in H. azteca[1].

Diclofenac methyl ester is a diclofenac (HY-15036) derivative, which exhibits acute cytotoxicity with a LC50 of 0.5 mg/L in H. azteca[1].

Diclofenac (Sodium) (Standard) is the analytical standard of Diclofenac (Sodium). This product is intended for research and analytical applications. Diclofenac Sodium (GP 45840) is a potent and nonselective anti-inflammatory agent, acts as a COX inhibitor, with IC50s of 4 and 1.3 nM for human COX-1 and COX-2 in CHO cells[1], and 5.1 and 0.84 μM […]

Dicyclohexano-18-crown-6-ether selectively extracts lysine-rich cytochrome c proteins from other cationic proteins under weakly acidic and neutral conditions, demonstrating specificity in ligand-protein interactions[1].